Neogen Total Assets 2010-2025 | NEOG
Neogen total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Neogen Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $4,549 |
| 2023 | $4,554 |
| 2022 | $993 |
| 2021 | $920 |
| 2020 | $797 |
| 2019 | $696 |
| 2018 | $618 |
| 2017 | $528 |
| 2016 | $450 |
| 2015 | $392 |
| 2014 | $345 |
| 2013 | $291 |
| 2012 | $252 |
| 2011 | $220 |
| 2010 | $180 |
| 2009 | $142 |
| Neogen Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-02-28 | $4,036 |
| 2024-11-30 | $4,054 |
| 2024-08-31 | $4,503 |
| 2024-05-31 | $4,549 |
| 2024-02-29 | $4,582 |
| 2023-11-30 | $4,602 |
| 2023-08-31 | $4,561 |
| 2023-05-31 | $4,554 |
| 2023-02-28 | $4,509 |
| 2022-11-30 | $4,563 |
| 2022-08-31 | $977 |
| 2022-05-31 | $993 |
| 2022-02-28 | $981 |
| 2021-11-30 | $968 |
| 2021-08-31 | $932 |
| 2021-05-31 | $920 |
| 2021-02-28 | $880 |
| 2020-11-30 | $846 |
| 2020-08-31 | $822 |
| 2020-05-31 | $797 |
| 2020-02-29 | $774 |
| 2019-11-30 | $751 |
| 2019-08-31 | $721 |
| 2019-05-31 | $696 |
| 2019-02-28 | $673 |
| 2018-11-30 | $660 |
| 2018-08-31 | $641 |
| 2018-05-31 | $618 |
| 2018-02-28 | $596 |
| 2017-11-30 | $581 |
| 2017-08-31 | $547 |
| 2017-05-31 | $528 |
| 2017-02-28 | $507 |
| 2016-11-30 | $487 |
| 2016-08-31 | $469 |
| 2016-05-31 | $450 |
| 2016-02-29 | $432 |
| 2015-11-30 | $426 |
| 2015-08-31 | $409 |
| 2015-05-31 | $392 |
| 2015-02-28 | $378 |
| 2014-11-30 | $366 |
| 2014-08-31 | $358 |
| 2014-05-31 | $345 |
| 2014-02-28 | $330 |
| 2013-11-30 | $320 |
| 2013-08-31 | $308 |
| 2013-05-31 | $291 |
| 2013-02-28 | $281 |
| 2012-11-30 | $270 |
| 2012-08-31 | $261 |
| 2012-05-31 | $252 |
| 2012-02-29 | $240 |
| 2011-11-30 | $234 |
| 2011-08-31 | $228 |
| 2011-05-31 | $220 |
| 2011-02-28 | $209 |
| 2010-11-30 | $204 |
| 2010-08-31 | $191 |
| 2010-05-31 | $180 |
| 2010-02-28 | $165 |
| 2009-11-30 | $161 |
| 2009-08-31 | $152 |
| 2009-05-31 | $142 |
| 2009-02-28 | $140 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.268B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.364B | 28.06 |
| Stryker (SYK) | United States | $146.969B | 30.73 |
| Boston Scientific (BSX) | United States | $146.968B | 36.79 |
| EssilorLuxottica (ESLOY) | France | $131.277B | 0.00 |
| Medtronic (MDT) | Ireland | $112.813B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.016B | 27.92 |
| ResMed (RMD) | United States | $37.047B | 27.83 |
| Agilent Technologies (A) | United States | $34.235B | 22.32 |
| GE HealthCare Technologies (GEHC) | United States | $33.847B | 16.07 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.399B | 16.10 |
| Insulet (PODD) | United States | $21.023B | 82.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.780B | 12.06 |
| Baxter (BAX) | United States | $16.278B | 12.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.165B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.273B | 21.83 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $4.281B | 19.13 |
| Perrigo (PRGO) | Ireland | $3.794B | 9.62 |
| Haemonetics (HAE) | United States | $3.466B | 15.79 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.367B | 24.83 |
| Envista Holdings (NVST) | United States | $3.244B | 26.96 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.091B | 14.38 |
| LeMaitre Vascular (LMAT) | United States | $1.890B | 42.24 |
| AtriCure (ATRC) | United States | $1.653B | 0.00 |
| Acuren (TIC) | United States | $1.314B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.136B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.053B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.987B | 12.61 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.640B | 0.00 |
| Evolus (EOLS) | United States | $0.636B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.634B | 0.00 |
| Owens & Minor (OMI) | United States | $0.629B | 5.22 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.422B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.367B | 13.50 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.334B | 59.50 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.276B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.00 |
| ZimVie (ZIMV) | United States | $0.266B | 12.09 |
| Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| Quanterix (QTRX) | United States | $0.256B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.216B | 57.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.16 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.105B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.88 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.43 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |